Amicus Therapeutics | 10-Q: Quarterly report
Amicus Therapeutics | 8-K: Amicus Therapeutics Announces First Quarter 2024 Financial Results and Corporate Updates
Amicus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Campbell Bradley L
Amicus Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Amicus Therapeutics | ARS: Annual Report to Security Holders
Amicus Therapeutics | DEFA14A: Others
Amicus Therapeutics | DEF 14A: Definitive information statements
Amicus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Prout Samantha
Amicus Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Amicus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Campbell Bradley L
Amicus Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Amicus Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Amicus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Campbell Bradley L
Amicus Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Campbell Bradley L
Amicus Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Crowley John F
Amicus Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Clark David Michael
Amicus Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Castelli Jeff
Amicus Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Rosenberg Ellen
Amicus Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Amicus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director SBLENDORIO GLENN
No Data